J. Goldman & Co LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
362
Total Value
2717381560
Accession Number
0001085146-25-003196
Form Type
13F-HR
Manager Name
J. Goldman & Co LP
Data Enrichment
89% identified
322 identified40 unidentified

Holdings

362 positions
Manager:
Search and click to pin securities to the top
Page 14 of 19
Scholar Rock Holding Corp
Shares:
40090(+32.7%)
Value:
$1.3B(-1.3%)
Sarepta Therapeutics, Inc.
Shares:
20000(-77.2%)
Value:
$1.3B(-88.0%)
Trevi Therapeutics, Inc.
Shares:
201107(+22245.2%)
Value:
$1.3B(+34014.4%)
JACK IN THE BOX INC
Shares:
46134(-85.6%)
Value:
$1.3B(-90.6%)
Corteva, Inc.
Shares:
19923(-86.7%)
Value:
$1.3B(-85.3%)
Akero Therapeutics, Inc.
Shares:
29326
Value:
$1.2B
ARGENX SE
Shares:
2000
Value:
$1.2B
GameStop Corp.
Shares:
52500
Value:
$1.2B
78468R556
Shares:
8708(+158.2%)
Value:
$1.1B(+156.9%)
GENUINE PARTS CO
Shares:
9600
Value:
$1.1B
Replimune Group, Inc.
Shares:
115861(+2.8%)
Value:
$1.1B(-17.2%)
TERAWULF INC.
Shares:
412500
Value:
$1.1B
Match Group, Inc.
Shares:
35000
Value:
$1.1B
Core Scientific, Inc./tx
Shares:
150000
Value:
$1.1B
464287184
Shares:
30000
Value:
$1.1B
Verastem, Inc.
Shares:
177237
Value:
$1.1B
464286707
Shares:
26249
Value:
$1.0B
MeiraGTx Holdings plc
Shares:
153600(-43.5%)
Value:
$1.0B(-37.1%)
BridgeBio Pharma, Inc.
Shares:
30000
Value:
$1.0B
89bio, Inc.
Shares:
142565
Value:
$1.0B